Recurrence of a high-titre factor VIII inhibitor in a haemophilia A patient on emicizumab prophylaxis

被引：8
作者：
Doshi, Bhavya S. [1 ,2 ]
Witmer, Char M. [1 ,2 ]
机构：
[1] Childrens Hosp Philadelphia, Div Hematol, 3501 Civ Ctr Blvd,CTRB 5024, Philadelphia, PA 19104 USA
[2] Univ Penn, Dept Pediat, Philadelphia, PA 19104 USA
来源：
HAEMOPHILIA | 2021年 / 27卷 / 04期
关键词：
emicizumab; haemophilia A; immune tolerance; inhibitor; recurrence; IMMUNE TOLERANCE;
D O I：
10.1111/hae.14311
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：E551 / E553
页数：3
相关论文
共 50 条
  • [21] Primary prophylaxis with rFVIIa in a patient with severe haemophilia a and inhibitor
    Jimenez-Yuste, Victor
    Quintana, Manuel
    Alvarez, Maria Teresa
    Martin-Salces, Monica
    Hernandez-Navarro, Fernando
    BLOOD COAGULATION & FIBRINOLYSIS, 2008, 19 (07) : 719 - 720
  • [22] Prophylaxis with emicizumab in 50 children and adolescents with severe haemophilia A without inhibitor in Uruguay: National experience
    Lemos, Felipe
    Petraccia, Carlos
    Laura Fraga, Maria
    Gomez, Rosario
    Lutz, Stefani
    Laura Casuriaga, Ana
    Inguanzo, Marianella
    Gonzalez, Jimena
    Echeverria, Silvina
    Gomez, Florencia
    Arocena, Maria
    Gonzalez, Yenirellys
    Giachetto, Gustavo
    Boggia, Beatriz
    HAEMOPHILIA, 2024, 30 : 96 - 97
  • [23] Knee joint arthroplasty in a patient with haemophilia A and high inhibitor titre using recombinant factor VIIa (NovoSeven®):: a new case report and review of the literature
    Faradji, A
    Bonnomet, F
    Lecocq, J
    Grunebaum, L
    Desprez, D
    Kern, O
    Barbier, L
    Sibilia, J
    HAEMOPHILIA, 2001, 7 (03) : 321 - 326
  • [24] Rapid Acquisition of Immunologic Tolerance to Factor VIII and Disappearance of Anti-factor VIII IgG4 After Prophylactic Therapy in a Hemophilia A Patient With High-titer Factor VIII Inhibitor
    Moorehead, Paul C.
    Thibeault, Lisa
    Tuttle, Angie
    Grabell, Julie
    Dwyre, Louise
    Silva, Mariana
    James, Paula
    Lillicrap, David
    JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY, 2015, 37 (04) : E220 - E222
  • [25] Successful second ITI with factor IX and combined immunosuppressive therapy A patient with severe haemophilia B and recurrence of a factor IX inhibitor
    Holstein, K.
    Schneppenheim, R.
    Schrum, J.
    Bokemeyer, C.
    Langer, F.
    HAMOSTASEOLOGIE, 2014, 34 (4A): : S5 - S8
  • [26] Target joint in a patient with severe haemophilia A on emicizumab prophylaxis: Follow-up of 24 weeks
    Arocena, Maria
    Petraccia, Carlos
    Inguanzo, Marianella
    Fraga, Maria Laura
    del Rosario Gomez, Maria
    Gonzalez, Jimena
    Lemos, Felipe
    Boggia, Beatriz
    HAEMOPHILIA, 2023, 29 : 44 - 45
  • [27] Unresponsiveness to factor VIII inhibitor bypassing agents during haemostatic treatment for life-threatening massive bleeding in a patient with haemophilia A and a high responding inhibitor
    Hayashi, T
    Tanaka, I
    Shima, M
    Yoshida, K
    Fukuda, K
    Sakurai, Y
    Matsumoto, T
    Giddings, JC
    Yoshioka, A
    HAEMOPHILIA, 2004, 10 (04) : 397 - 400
  • [28] Use of factor VIII after inhibitor clearance in patients with moderate haemophilia A: a case series
    Tran, D. Q.
    Harvey, R. D.
    Meeks, S. L.
    Chapman, R.
    Kempton, C. L.
    HAEMOPHILIA, 2014, 20 (04) : e344 - e346
  • [29] Laparoscopic Hepatectomy for the Patient with Hemophilia A with High Titer Factor VIII Inhibitor
    Matsuda, Tatsuo
    Umeda, Yuzo
    Yoshida, Kazuhiro
    Matsud, Tadakazu
    Uno, Masatoshi
    Abe, Masaya
    Asada, Noboru
    Maeda, Yoshinobu
    Yagi, Takahito
    Fujiwara, Toshiyoshi
    ACTA MEDICA OKAYAMA, 2021, 75 (02) : 199 - 204
  • [30] Surgical Experience from the STASEY Study of Emicizumab Prophylaxis in People with Hemophilia A with Factor VIII Inhibitors
    Castaman, Giancarlo
    Peyvandi, Flora
    Hovinga, Johanna A. Kremer
    Schutgens, Roger E. G.
    Robson, Susan
    Moreno, Katya
    Jimenez-Yuste, Victor
    TH OPEN, 2024, 08 (01) : e42 - e54
12345